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Introduction
In recent decades, a number of devices and al-
ternatives to conventional manual cardio-pulmonary
resuscitation (CPR) have been developed. The driv-
ing force behind these developments has been the
desire to enhance perfusion during attempted resus-
citation from cardiac arrest. The ultimate goal of
device-assisted resuscitation during cardiac arrest
is long-term survival with preservation of brain
function.
The Lancet has published two studies [1, 2]
comparing standard CPR to CPR using ResQPod
combined with another assist device called the
ResQPump (Fig. 1), both from Advanced Circula-
tory Systems, Inc (Roseville, MN, USA).
ResQPump is an active compression-decom-
pression (ACD) hand-held device and ResQPod is
an inspiratory impedance threshold valve device
(ITD). The application of these two devices during
CPR (ITD + ACD-CPR) as shown in Fig. 1 results
in an increase in blood flow to the heart and brain
compared to standard (S-) CPR and improves clini-
cal outcomes (Fig. 2).
The ResQPump (Fig. 3) is a hand-held, ACD
CPR device placed in the same position on the ster-
num as the hands, enabling rescuers to perform sim-
ilar chest compressions as in conventional CPR.
Instead of allowing the chest wall to recoil passive-
ly however, rescuers pull up on the ResQPump’s
handle with its suction cup. This provides active de-
compression of the chest, promotes optimal chest
wall recoil, and creates a negative intrathoracic
pressure (vacuum) that helps the return of blood
to the heart. The handle contains a force gauge and
metronome that guide compression depth, recoil
and rate. The ResQPump is identical to the Car-
dioPump, an ACD-CPR device available outside the
United States.
The ITD (Fig. 4) is a small, 35-mL device that
fits on a face mask or an endotracheal tube. The
pressure-sensitive valves within the ITD impede
the influx of inspiratory gas during chest wall de-
compression, thereby augmenting the amplitude
and duration of the vacuum within the thorax. This
vacuum draws more venous blood back into the
heart, resulting in increased cardiac preload, fol-
lowed by improved cardiac output and vital organ
perfusion.
It is attached within the ventilation circuit be-
tween the airway device and the ventilation source.
By selectively restricting airflow during CPR, the
device creates a small but important negative pres-
sure (vacuum) in the chest. This has been shown in
numerous human and animal clinical trials to increase
blood flow back to the patient’s heart during CPR.
ResQTrial summary
The trial was conducted at seven co-ordinat-
ing EMS sites in the US: Minneapolis, MN; St. Paul,
MN; Whatcom County, WA; Oshkosh, WI; Oakland
and Macomb Counties, MI; Washtenaw and Living-
ston Counties, MI; Indianapolis, Indianapolis.
It included 46 EMS agencies in urban, subur-
ban and rural areas, covering a total population of 2.3
million. The study protocol was reviewed and ap-
proved by 25 participating Hospital Review Boards.
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Figure 1. Cardio-pulmonary resuscitation using ResQPod
combined with an active compression-decompression
assist device called a ResQPump.
Figure 2. Improved perfusion using an active compres-
sion-decompression ResQPump device.
Figure 3. An active compression-decompression hand-
-held device, ResQPump.
Figure 4. Inspiratory impedance threshold valve device, ResQPod.
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Study population
A total of 2,470 patients were randomized, with
1,653 of them meeting the final criteria: 813 in the
control group and 840 in the intervention group.
Eligible patients experiencing presumed car-
diac arrest were randomized over about three and
a half years to undergo CPR either with, or with-
out, the ACD technique.
The hospital-survival rate was statistically simi-
lar in the intervention group and the control group,
but the primary end point of hospital discharge with
good neurological function (defined as a modified
Rankin score £ 3) was significantly higher in the
intervention group (odds ratio [OR] 1.58, 95% con-
fidence interval [CI] 1.07–2.36; p = 0.019). Those
patients also showed better one-year survival, but
a significantly increased rate of pulmonary edema
(Table 1).
Key trial results
— Patients in the intervention group had a 53%
relative increase in survival to hospital dischar-
ge with a mRS score of £ 3 (primary endpo-
int): 75/840 (8.9%) vs 47/813 (5.8%), p = 0.019,
OR 1.58, 95% CI 1.07–2.36.
— There were no survivors in either group if CPR
was initiated > 10 min after the call to the
emergency services.
— For patients with an initial recorded rhythm of
VF/VT: survival to hospital discharge with
MRS £ 3 was greater in the intervention gro-
up: 23% vs 17%, p = 0.0645 (non-significant).
— One year after cardiac arrest, there was a 49%
increase in survival in the intervention group:
74/840 (8.8%) vs 48/813 (5.9%) in the control
group, p = 0.030.
— The overall rate of major adverse events was
not significantly different between groups.
There were more reports of pulmonary edema
in the intervention group, but there was also
increased survival in this group.
— Neurological function was similar between gro-
ups at 90 days and one year after cardiac ar-
rest. There was no increase in the number of
patients with severe neurological impairment
in the intervention group.
— Results were consistent across study sites,
patient age groups, gender.
Conclusions
— ACD-CPR with augmentation of negative intra-
thoracic pressure using an ITD improves su-
rvival to hospital discharge with favorable neu-
rological function. The survival benefit persi-
sted to one year following cardiac arrest.
— The combination of ITD + ACD-CPR has an
acceptable safety profile for use in patients with
cardiac arrest.
— The combination of ITD + ACD-CPR is feasi-
ble to teach and implement in a variety of EMS
environments.
— These results support the routine use of
ITD + ACD-CPR during cardiac arrest to
increase survival to hospital discharge with
favorable neurological function.
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Table 1. Discharge with favorable neurological function, survival, and adverse event rates,
cardio-pulmonary resuscitation (CPR) with ResQ interventions vs standard CPR.
End point CPR with ResQ Standard CPR p
interventions (n = 840) (n = 813)
Discharge with favorable neurological function* 9% 6% 0.019
Survival to discharge 12% 10% 0.12
Survival at one year 9% 6% 0.03
≥ one major adverse event 94% 94% 0.68
Pulmonary edema 11% 8% 0.015
*Primary end point, defined as a modified Rankin score of £ 3 at hospital discharge
